Induction of defective insulin secretion and impaired glucose tolerance by clonidine. Selective stimulation of metabolic alpha-adrenergic pathways

Keyphrases

• Insulin Secretion 100%
• Metabolic 100%
• α-adrenergic 100%
• Impaired Glucose Tolerance 100%
• Clonidine 100%
• Adrenergic Pathway 100%
• Selective Stimulation 100%
• Plasma Glucose 28%
• Glucagon 28%
• Insulinoma 28%
• Urinary Catecholamines 28%
• Tumor 14%
• Hyperglycemia 14%
• Male Subjects 14%
• Operative 14%
• Cervical Spinal Cord 14%
• Resection 14%
• Phentolamine 14%
• Vascular Tone 14%
• Intravenous Glucose 14%
• Vasomotor 14%
• Plasma Insulin 14%
• Insulin Concentration 14%
• Acute Insulin Response 14%
• Blocking Agent 14%
• Antihypertensive Drugs 14%
• Endogenous Catecholamines 14%
• Normal Response 14%
• Catecholamine Levels 14%
• Expected Response 14%
• Metabolic Alterations 14%
• Adrenergic Mechanisms 14%
• Paraplegic Patients 14%
• Oral Clonidine 14%
• Catecholamine Secretion 14%
• Glucoregulatory Hormones 14%
• Glucose Injection 14%

Medicine and Dentistry

• Insulin Release 100%
• Impaired Glucose Tolerance 100%
• Clonidine 100%
• Adrenergic 100%
• Catecholamine 37%
• Nesidioblastosis 25%
• Glucagon 25%
• Neoplasm 12%
• Single Drug Dose 12%
• Infusion 12%
• Antihypertensive Agent 12%
• Hyperglycemia 12%
• Blood Vessel Tone 12%
• Vasomotor 12%
• Insulin Response 12%
• Alpha Adrenergic Receptor Blocking Agent 12%
• Catecholamine Release 12%
• Cervical Spinal Cord 12%
• Phentolamine 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Clonidine 100%
• Impaired Glucose Tolerance 100%
• Catecholamine 37%
• Insulinoma 25%
• Glucagon 25%
• Normal Human 12%
• Phentolamine 12%
• Antihypertensive Agent 12%
• Alpha Adrenergic Receptor Blocking Agent 12%
• Neoplasm 12%
• Hyperglycemia 12%